Dr. Attila Köfalvi is a neurobiologist at the Center for Neuroscience and Cell Biology of Coimbra at the Faculty of Medicine of the University of Coimbra, Coimbra, Portugal since 2004. He currently holds the position of research associate, and is head of his research group called "Laboratory of Neuromodulation and Metabolism". In 2009, he became a Young Investigator of the Network of European Neuroscience Institutes.

He is integrated in the network of Associate Laboratories of the Portuguese Science Foundation

He is also holding associate researcher position at the Institute for Interdisciplinary Research since 2010. 



To see the research interest of the group of Dr. Attila Köfalvi follow this link.



Dr. Attila Köfalvi graduated as a functional and developmental biologist with specialization in neurobiology in 1999 at the Faculty of Sciences, Eötvös Loránd University, Budapest, Hungary. In 2004, he obtained his PhD degree with Summa cum Laude, in a joint PhD programme in Neurobiology at the Semmelweis Medical University, Budapest, Hungary, at the Institute of Experimental Medicine, Budapest as well at the Nathan Smith Kline Institute in Orangeburg, NY, USA.


Other qualifications

Dr. Attila Köfalvi holds Good Laboratory Practice certificate (2001) and Category "C" qualification for directing animal experiments from the Federation of European Laboratory Animal Science Associations (2009).

Professional profiles and metrics


ORCID             Google Scholar             PubMed              ResearcherID   


ENI-Net                 LinkedIn                 ResearchGate               Loop                             

Dr. Attila Köfalvi is the Editor and co-author of the book "Cannabinoids and the Brain" - Springer-Verlag US. 

You can access via this link our new review article about cannabis and the endocannabinoid system, entitled "Cannabis - A Treasure Trove or Pandora's Box?"

Factos e mítos sobre a marijuana: escute o meu podcast: http://www.cnbc.pt/podcast/Attila_VF.mp3



Notícia no Diário as Beiras

Clica aqui para ouvir a notícia de rádio sobre a nossa descoberta recente: o potencial terapêutico dos agonistas do receptor canabinóide CB2 na doença de Alzheimer.

E a notícia on-line no jornal Sapo.

E o artigo destacado nas notícias: Cannabinoid CB2 receptor activation stimulates glucose uptake in the brain.


Phone (lab): (00351)-304-502-916

E-mail: akofalvi@uc.pt            alternative e-mail: akofalvi@yahoo.com

Directions, letters: Center for Neurosciences and Cell Biology of Coimbra,

Faculty of Medicine, University of Coimbra, 1 Rua Larga (Polo I), 3004-504 Coimbra, Portugal

A sua fotografia
QrCode uc40923
QR Code ?